We are the leading consultancy for pharmaceutical and medical product companies. In the UK, we have supported clients on more than 300 projects in the past five years.
What we do
We are the industry’s leading consultancy on strategy, R&D, operations and commercial topics. The range of our work gives us a comprehensive perspective on the issues our clients face, such as how to:
- Achieve growth
- Prioritise R&D investments
- Develop innovative and distinctive products
- Capture the healthcare data opportunity.
Who we are
Our London office has more than 40 specialist healthcare consultants with advanced degrees in life science or medicine. To gain additional insights, we consult an extensive network of external experts who serve on our standing teams for different therapeutic areas, such as diabetes, oncology, central nervous system and other major disease areas. Overall, these advisory boards include more than 120 world-class external advisers who are leaders in their fields.
Knowledge and networks
We invest in primary research to create cutting-edge tools, training programmes and databases, such as:
- Tools for benchmarking R&D performance (SuccessLab), commercial performance (Insights PharmaCo and Live Launch), clinical operations (Clinical Trial Impact), pharmaceutical operations (POBOS) and medical affairs (MAPES)
- Best practices for improving the long-term performance and health of pharmaceutical companies, developed by drawing on more than 120,000 data points from our Organisational Health Index, which covers hundreds of companies across all industries
- A proprietary tool to help clients identify patients with undiagnosed conditions by applying an advanced algorithm (Disease Analyser) to medical records, and follow up with patients via physician or nursing programmes.